NCT06689423View on ClinicalTrials.gov

Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay

Not yet recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
SARS-CoV-2COVID-19RSVInfluenza
Interventions
DEVICE

Credo POCT Device

Testing Credo's POCT device for respiratory viruses detection.

Trial Locations (1)

Unknown

Credo Diagnostics Biomedical Pte Ltd. Taiwan Branch, New Taipei City

Sponsors
All Listed Sponsors
collaborator

Medical College of Wisconsin

OTHER

lead

Credo Diagnostics Biomedical Pte. Ltd.

INDUSTRY